Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Maisel

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
European Heart Journal. Acute Cardiovascular Care|January 31, 2014
Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency departmentSalvatore Di Somma, Irene Lalle, Laura Magrini, et al.
Psychosomatic Medicine|November 7, 2014
Leukocyte ß-adrenergic receptor sensitivity and depression severity in patients with heart failureLaura S Redwine, Suzi Hong, Thomas Rutledge, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 22, 2017
Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18Martin Möckel, Anna Slagman, Jörn Ole Vollert, et al.
Journal of Cardiac Failure|October 17, 2019
Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine AbuseIsac C Thomas, Marin Nishimura, Janet Ma, et al.
Clinical Cardiology|April 25, 2019
Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitusPaul J Mills, Pam R Taub, Ottar Lunde, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2014
Opinion paper on utility of point-of-care biomarkers in the emergency department pathways decision makingSalvatore Di Somma, Giorgio Zampini, Francesco Vetrone, et al.
American Heart Journal|May 15, 2018
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)James L Januzzi, Javed Butler, Emmanuel Fombu, et al.
Journal of Hypertension|April 25, 2015
Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosisOtto A Sanchez, David R Jacobs, Hossein Bahrami, et al.
Journal of Cardiac Failure|December 3, 2014
The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failureYuhui Zhang, Rongcheng Zhang, Tao An, et al.
European Journal of Preventive Cardiology|April 6, 2011
B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic functionAlberto Palazzuoli, Maria Caputo, Massimo Fineschi, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
European Heart Journal. Acute Cardiovascular Care|January 31, 2014
Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency departmentSalvatore Di Somma, Irene Lalle, Laura Magrini, et al.
Psychosomatic Medicine|November 7, 2014
Leukocyte ß-adrenergic receptor sensitivity and depression severity in patients with heart failureLaura S Redwine, Suzi Hong, Thomas Rutledge, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 22, 2017
Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18Martin Möckel, Anna Slagman, Jörn Ole Vollert, et al.
Journal of Cardiac Failure|October 17, 2019
Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine AbuseIsac C Thomas, Marin Nishimura, Janet Ma, et al.
Clinical Cardiology|April 25, 2019
Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitusPaul J Mills, Pam R Taub, Ottar Lunde, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2014
Opinion paper on utility of point-of-care biomarkers in the emergency department pathways decision makingSalvatore Di Somma, Giorgio Zampini, Francesco Vetrone, et al.
American Heart Journal|May 15, 2018
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)James L Januzzi, Javed Butler, Emmanuel Fombu, et al.
Journal of Hypertension|April 25, 2015
Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosisOtto A Sanchez, David R Jacobs, Hossein Bahrami, et al.
Journal of Cardiac Failure|December 3, 2014
The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failureYuhui Zhang, Rongcheng Zhang, Tao An, et al.
European Journal of Preventive Cardiology|April 6, 2011
B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic functionAlberto Palazzuoli, Maria Caputo, Massimo Fineschi, et al.
Pageof 15